<DOC>
	<DOCNO>NCT02633930</DOCNO>
	<brief_summary>This study aim evaluate efficacy safety berberine-containing quadruple therapy ( berberine , lansoprazole , bismuth amoxicillin ) versus clarithromycin-containing quadruple therapy ( clarithromycin , lansoprazole , bismuth amoxicillin ) H. pylori eradication . It hypothesize berberine-containing quadruple therapy non-inferior clarithromycin-containing quadruple therapy . Patients confirm H. pylorus positive status randomize one treatment describe . At week 2 6 follow-up visit , urea breath test ( UBT ) perform confirm eradication .</brief_summary>
	<brief_title>Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy</brief_title>
	<detailed_description>The study include three phase : screening , treatment follow-up . Screening : phase last maximum 28 day subject eligibility evaluate informed consent signature . Endoscopy Urea Breath test perform addition baseline routine evaluation . Treatment : Subjects randomly assign treatment treat 14 day . A randomization visit take place Day 0 end-of-treatment visit take place day 12 14 . Follow-up : include two visit . approximately 14 day treatment 28 day end treatment . Eradication H. Pylori confirm urea breath test ( UBT ) .</detailed_description>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Gastritis</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Bismuth</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>1 . Age 18~70 , gender . 2 . Patients upper gastrointestinal symptom document H.pylori infection . 3 . Patients willing receive eradication treatment . 4 . Women eligible pregnant nursing , childbearing potential require use medically acceptable contraception duration study 30 day thereafter . 1 . Patients exclude previously use antibiotic eradicate adequately record infection H. pylorus . 2 . Contraindications study drug . 3 . Substantial organ impairment , severe unstable cardiopulmonary endocrine disease . 4 . Constant use antiulcer drug ( include take protonpump . inhibitor ( PPI ) within 2 week [ 13C ] urea breath test ) , antibiotic bismuth complex ( 3 time /1 month screen ) 5 . Pregnant lactating woman . 6 . Underwent upper gastrointestinal Surgery . 7 . Patients Barrett esophageal highly atypical hyperplasia , symptom dysphagia . 8 . Evidence bleed iron efficiency anemia . 9 . A history malignancy . 10 . Drug alcohol abuse history past 1 year . 11 . Systemic use corticosteroid , non steroidal antiinflammatory drug , anticoagulant , platelet aggregation inhibitor ( except use aspirin le 100 mg/d ) . 12 . Enrolled clinical trial past 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>helicobacter pylorus</keyword>
	<keyword>berberine-containing quadruple therapy</keyword>
	<keyword>clarithromycin-containing quadruple therapy</keyword>
</DOC>